Frontiers in Cardiovascular Medicine | Lipids in Cardiovascular Disease

Original Research

Published on 26 Jul 2024

Genetic testing for familial hypercholesterolemia in a Finnish cohort of patients with premature coronary artery disease and elevated LDL-C levels

in Lipids in Cardiovascular Disease

Antti Jokiniitty
Markku Eskola
Saara Metso
Martin Bogsrud
Heini Huhtala
Tanja Saarela

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1433042

2,449 views

Original Research

Published on 25 Jul 2024

Association between homocysteine levels and hyperlipidemia prevalence as well as all-cause mortality of hyperlipidemia patients in the US population: results from NHANES database

in Lipids in Cardiovascular Disease

Jia Wei
Qiang Yang
Xiaofang Wang
Xin He
Wenjing Zhu
Lin Lin
Chang Liu
Canzhan Zhu
Mingjuan Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1419579

4,209 views
5 citations

Correction

Published on 18 Jul 2024

Corrigendum: Genetically predicted lipids mediate the association between intrahepatic cholestasis of pregnancy and cardiovascular disease

in Lipids in Cardiovascular Disease

Ji Cui
Qilong Zhai
Mengjie Chen
Zhu Yang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1439868

1,279 views

Original Research

Published on 17 Jul 2024

Enhanced atherosclerosis in apolipoprotein E knockout rabbits: role of apoB48-rich remnant lipoproteins

in Lipids in Cardiovascular Disease

Manabu Niimi
Yajie Chen
Huanyu Zhao
Xiangming Tang
Fumikazu Matsuhisa
Huanjin Zhou
Haizhao Yan
Lu Chen
Shuji Kitajima
Akira Sato

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1424064

3,218 views
4 citations

Systematic Review

Published on 11 Jul 2024

Traditional Chinese medicine lowering lipid levels and cardiovascular events across baseline lipid levels among coronary heart disease: a meta-analysis of randomized controlled trials

in Lipids in Cardiovascular Disease

Lihua Xie
Jia Liu
Xiaochi Wang
Birong Liu
Jiaqi Li
Jingen Li
Huanlin Wu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1407536

4,127 views
2 citations

Original Research

Published on 10 Jul 2024

Adherence to the 2018 AHA cholesterol management guideline in hyperlipidemia treatment among adults in an outpatient setting

in Lipids in Cardiovascular Disease

Bahere Behdani
Toba Kazemi
Mahmood Zardast
Saeede Khosravi Bizhaem
Shima Jafari

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1340311

3,586 views
1 citation

Brief Research Report

Published on 09 Jul 2024

Trends and findings of lipoprotein(a) testing and associated cardiovascular disease profiles: a large single-center study from the Middle East-Gulf region

in Lipids in Cardiovascular Disease

Yosef Manla
Laila AbdelWareth
Ronney Shantouf
Yazan Aljabery
Terrence Lee St John
Hani Sabbour
Bartlomiej Piechowski-Jozwiak
Wael Almahmeed

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1439013

6,710 views
3 citations

Review

Published on 25 Jun 2024

PCSK9 inhibition: from effectiveness to cost-effectiveness

in Lipids in Cardiovascular Disease

Iveta Mercep
Dominik Strikic
Pero Hrabac
Ivan Pecin
Željko Reiner

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1339487

6,669 views
19 citations

Original Research

Published on 30 Apr 2024

Genetically predicted lipids mediate the association between intrahepatic cholestasis of pregnancy and cardiovascular disease

in Lipids in Cardiovascular Disease

Ji Cui
Qilong Zhai
Mengjie Chen
Zhu Yang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1401010

2,891 views
2 citations

Review

Published on 04 Apr 2024

Biomechanics-mediated endocytosis in atherosclerosis

in Lipids in Cardiovascular Disease

Jinxuan Wang
Jianxiong Xu
Tianhu Liu
Chaoping Yu
Fengcheng Xu
Guixue Wang
Shun Li
Xiaozhen Dai

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1337679

4,721 views
6 citations

Original Research

Published on 25 Mar 2024

The impact of dyslipidemia on prognosis of patients after endovascular abdominal aortic aneurysm repair

in Lipids in Cardiovascular Disease

Xin Luo
Qiang Guo
Jiarong Wang
Yiyuan Li
Jichun Zhao
Bin Huang
Xiyang Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1341663

2,055 views

Case Report

Published on 12 Mar 2024

Case Report: Neurological adverse events in subject with myasthenia gravis after PCSK9 inhibitor administration

in Lipids in Cardiovascular Disease

Věra Adámková
Martina Vitásková
Jaroslav A. Hubáček

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1343775

4,836 views
3 citations

Original Research

Published on 07 Mar 2024

Lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients in non-metropolitan areas of Brandenburg, Germany

in Lipids in Cardiovascular Disease

Philipp Hillmeister
Kangbo Li
Mengjun Dai
Mesud Sacirovic
Nikolaos Pagonas
Oliver Ritter
Peter Bramlage
Anja Bondke Persson
Ivo Buschmann
Claudia Zemmrich

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1302152

3,791 views
2 citations

Original Research

Published on 16 Feb 2024

Trehalose promotes atherosclerosis regression in female mice

in Lipids in Cardiovascular Disease

Sabrina Robichaud
Valérie Rochon
Christina Emerton
Thomas Laval
Mireille Ouimet

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1298014

7,275 views
8 citations

Original Research

Published on 07 Feb 2024

Elevated remnant cholesterol and non-HDL cholesterol concentrations from real-world laboratory results: a cross-sectional study in Southeast Asians

in Lipids in Cardiovascular Disease

Wann Jia Loh
Heng Samuel Soh
Mon Hnin Tun
Pei Ting Tan
Chin Shern Lau
Subramaniam Tavintharan
Gerald F. Watts
Tar Choon Aw

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1328618

3,441 views
3 citations

Mini Review

Published on 25 Jan 2024

The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience

in Lipids in Cardiovascular Disease

Chad Gier
Ian Gilchrist
Matthew Fordham
Luke Riordan
Ella Milchan
Nidhi Patel
Azad Mojahedi
Sahana Choudhury
Tara Kits
Regina Cohen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1284562

3,099 views
4 citations

Original Research

Published on 22 Jan 2024

Epidemiology of atherosclerotic cardiovascular disease in polygenic hypercholesterolemia with or without high lipoprotein(a) levels

in Lipids in Cardiovascular Disease

Pierandrea Vinci
Nicola Fiotti
Emiliano Panizon
Letizia Maria Tosoni
Carla Cerrato
Federica Pellicori
Alessia Pirulli
Nicola Altamura
Paolo Schincariol
Filippo Giorgio Di Girolamo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1272288

3,547 views
1 citation

Original Research

Published on 22 Jan 2024

A polyphenol-rich plant extract prevents hypercholesterolemia and modulates gut microbiota in western diet-fed mice

in Lipids in Cardiovascular Disease

Cédric Langhi
Marie Vallier
Auriane Bron
Yolanda F. Otero
Maheva Maura
Florian Le Joubioux
Niek Blomberg
Martin Giera
Bruno Guigas
Thierry Maugard

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1342388

5,221 views
9 citations

Editorial

Published on 08 Jan 2024

Editorial: Sphingolipids in cardiovascular diseases: from pathogenesis to therapeutics

in Lipids in Cardiovascular Disease

Massimo Collino
Marco Piccoli

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1330274

1,691 views

Original Research

Published on 07 Dec 2023

Bidirectional causal relationship between hypercholesterolemia and ischemic heart disease: a Mendelian randomization study

in Lipids in Cardiovascular Disease

Ying Jiang
Wenpeng Yu
Jianliang Zhou
Xiao Dong

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1302282

4,495 views
4 citations

Original Research

Published on 06 Dec 2023

Relationships between body composition, anthropometrics, and standard lipid panels in a normative population

in Lipids in Cardiovascular Disease

Marcus Weeks
Andrew D. Delgado
Jamie Wood
Bodi Zhang
Sarah Pesce
Laura Kunces
Loukia Lili
David Putrino

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1280179

3,393 views
2 citations

Original Research

Published on 27 Nov 2023

Association of remnant cholesterol with CVD incidence: a general population cohort study in Southwest China

in Lipids in Cardiovascular Disease

Chengxi Liu
Mi Dai
Kunming Tian
Shiyu Zhou
Lei Luo
Zhiying Zeng
Xuelian Yan
Ying Xiao
Yiying Wang
Renli Deng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1286286

3,239 views
4 citations

Review

Published on 24 Nov 2023

Ezetimibe and atherosclerotic cardiovascular disease: a systematic review and meta-analysis

in Lipids in Cardiovascular Disease

Fatemeh Omidi
Maryam Rahmannia
Amir Hashem Shahidi Bonjar
Parsa Mohammadsharifi
Mohammad Javad Nasiri
Tala Sarmastzadeh

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1269172

6,190 views
4 citations

Editorial

Published on 01 Nov 2023

Editorial: Lipids, lipoproteins and COVID-19

in Lipids in Cardiovascular Disease

Mualla Ozcan
Xuewei Zhu
Hanrui Zhang
Ali Javaheri

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1293249

2,117 views
2 citations

277 articles

articles

Genetic testing for familial hypercholesterolemia in a Finnish cohort of patients with premature coronary artery disease and elevated LDL-C levels

Association between homocysteine levels and hyperlipidemia prevalence as well as all-cause mortality of hyperlipidemia patients in the US population: results from NHANES database

Corrigendum: Genetically predicted lipids mediate the association between intrahepatic cholestasis of pregnancy and cardiovascular disease

Enhanced atherosclerosis in apolipoprotein E knockout rabbits: role of apoB48-rich remnant lipoproteins

Traditional Chinese medicine lowering lipid levels and cardiovascular events across baseline lipid levels among coronary heart disease: a meta-analysis of randomized controlled trials

Adherence to the 2018 AHA cholesterol management guideline in hyperlipidemia treatment among adults in an outpatient setting

Trends and findings of lipoprotein(a) testing and associated cardiovascular disease profiles: a large single-center study from the Middle East-Gulf region

PCSK9 inhibition: from effectiveness to cost-effectiveness

Genetically predicted lipids mediate the association between intrahepatic cholestasis of pregnancy and cardiovascular disease

Biomechanics-mediated endocytosis in atherosclerosis

The impact of dyslipidemia on prognosis of patients after endovascular abdominal aortic aneurysm repair

Case Report: Neurological adverse events in subject with myasthenia gravis after PCSK9 inhibitor administration

Lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients in non-metropolitan areas of Brandenburg, Germany

Trehalose promotes atherosclerosis regression in female mice

Elevated remnant cholesterol and non-HDL cholesterol concentrations from real-world laboratory results: a cross-sectional study in Southeast Asians

The role of structured inpatient lipid protocols in optimizing non-statin lipid lowering therapy: a review and single-center experience

Epidemiology of atherosclerotic cardiovascular disease in polygenic hypercholesterolemia with or without high lipoprotein(a) levels

A polyphenol-rich plant extract prevents hypercholesterolemia and modulates gut microbiota in western diet-fed mice

Editorial: Sphingolipids in cardiovascular diseases: from pathogenesis to therapeutics

Bidirectional causal relationship between hypercholesterolemia and ischemic heart disease: a Mendelian randomization study

Relationships between body composition, anthropometrics, and standard lipid panels in a normative population

Association of remnant cholesterol with CVD incidence: a general population cohort study in Southwest China

Ezetimibe and atherosclerotic cardiovascular disease: a systematic review and meta-analysis

Editorial: Lipids, lipoproteins and COVID-19